Literature DB >> 9576007

Enhanced lymphoproliferation and diminished autoimmunity in CD4-deficient MRL/lpr mice.

M S Chesnutt1, B K Finck, N Killeen, M K Connolly, H Goodman, D Wofsy.   

Abstract

MRL/lpr mice spontaneously develop an autoimmune disease with features of systemic lupus erythematosus. They also develop a lymphoproliferative disorder characterized by a massive accumulation of double-negative (DN) T cells that lack both CD4 and CD8. To clarify the role of CD4 in autoimmunity and lymphoproliferation in these mice, CD4-deficient MRL/lpr mice were generated. CD4-deficient MRL/lpr mice developed massive expansion of DN T cells in the blood, spleen, and lymph nodes, which significantly exceeded the degree of lymphoproliferation in CD4-expressing control MRL/lpr mice. Despite this lymphoproliferation, CD4-deficient MRL/lpr mice produced little, if any, antibodies to double-stranded DNA, and they had prolonged survival relative to CD4-expressing littermates. However, they eventually developed moderately severe nephritis, characterized by immunoglobulin and complement deposition in glomeruli, vasculitis, and renal infiltration by CD8+ T cells. These findings indicate that (1) lymphoproliferation in MRL/lpr mice does not require the expression of CD4; (2) autoantibody production in MRL/lpr mice is dependent on the expression of CD4 and not on the accumulation of DN T cells; and (3) the development of nephritis in MRL/lpr mice involves both CD4-dependent and CD4-independent mechanisms.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9576007     DOI: 10.1006/clin.1997.4492

Source DB:  PubMed          Journal:  Clin Immunol Immunopathol        ISSN: 0090-1229


  16 in total

Review 1.  The regulation and activation potential of autoreactive B cells.

Authors:  Michele L Fields; Su-Jean Seo; Simone A Nish; Jeff H Tsai; Andrew J Caton; Jan Erikson
Journal:  Immunol Res       Date:  2003       Impact factor: 2.829

Review 2.  Dysregulated Lymphoid Cell Populations in Mouse Models of Systemic Lupus Erythematosus.

Authors:  Aurélie De Groof; Patrice Hémon; Olivier Mignen; Jacques-Olivier Pers; Edward K Wakeland; Yves Renaudineau; Bernard R Lauwerys
Journal:  Clin Rev Allergy Immunol       Date:  2017-10       Impact factor: 8.667

Review 3.  Future prospects in biologic therapy for systemic lupus erythematosus.

Authors:  William Stohl
Journal:  Nat Rev Rheumatol       Date:  2013-09-10       Impact factor: 20.543

4.  The effect on immunoglobulin glycosylation of altering in vivo production of immunoglobulin G.

Authors:  P Jeddi; J Keusch; P M Lydyard; K B Bodman-Smith; M S Chesnutt; D Wofsy; H Hirota; T Taga; P J Delves
Journal:  Immunology       Date:  1999-11       Impact factor: 7.397

5.  Identification of T-cell epitopes on U1A protein in MRL/lpr mice: double-negative T cells are the major responsive cells.

Authors:  Mei-Hui Yang; Jau-Ling Suen; Shiao-Lan Li; Bor-Luen Chiang
Journal:  Immunology       Date:  2005-06       Impact factor: 7.397

Review 6.  Use of genetic knockouts to modulate disease expression in a murine model of lupus, MRL/lpr mice.

Authors:  Christopher M Reilly; Gary S Gilkeson
Journal:  Immunol Res       Date:  2002       Impact factor: 2.829

7.  The beneficial effects of treatment with all-trans-retinoic acid plus corticosteroid on autoimmune nephritis in NZB/WF mice.

Authors:  Y Nozaki; T Yamagata; B-S Yoo; M Sugiyama; S Ikoma; K Kinoshita; M Funauchi; A Kanamaru
Journal:  Clin Exp Immunol       Date:  2005-01       Impact factor: 4.330

8.  Identification of systemically expanded activated T cell clones in MRL/lpr and NZB/W F1 lupus model mice.

Authors:  G Zhou; K Fujio; A Sadakata; A Okamoto; R Yu; K Yamamoto
Journal:  Clin Exp Immunol       Date:  2004-06       Impact factor: 4.330

9.  Contribution of alphabeta and gammadelta T cells to the generation of primary immunoglobulin G-driven autoimmune response in immunoglobulin- mu-deficient/lpr mice.

Authors:  Jane Seagal; Doron Melamed
Journal:  Immunology       Date:  2004-06       Impact factor: 7.397

10.  Programmed death ligand 1 regulates a critical checkpoint for autoimmune myocarditis and pneumonitis in MRL mice.

Authors:  Julie A Lucas; Julia Menke; Whitney A Rabacal; Frederick J Schoen; Arlene H Sharpe; Vicki R Kelley
Journal:  J Immunol       Date:  2008-08-15       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.